News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
195 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17773)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (202)
2 (163)
3 (150)
4 (1)
6 (113)
7 (192)
8 (195)
9 (146)
10 (94)
11 (1)
12 (5)
13 (183)
14 (272)
15 (209)
16 (183)
17 (86)
18 (3)
19 (5)
20 (142)
21 (207)
22 (173)
23 (165)
24 (67)
25 (3)
26 (3)
27 (139)
28 (227)
29 (177)
30 (210)
31 (85)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Savaria’s Revenue Up 61% and Adjusted EBITDA Up 50% for Second Quarter of 2018
Savaria Corporation discloses results for its second quarter ended June 30, 2018.
August 8, 2018
·
7 min read
Business
Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Adverum Biotechnologies, Inc. reported financial results for the second quarter ended June 30, 2018 and provided a corporate update.
August 8, 2018
·
8 min read
Business
Wright Medical Group N.V. Reports 2018 Second Quarter Financial Results
Second Quarter 2018 Net Sales of $205 Million
August 8, 2018
·
24 min read
Business
Sangamo Therapeutics Reports Second Quarter 2018 Financial Results
Company Also Separately Announced Positive Preliminary Data from Phase 1/2 Clinical Trial Evaluating SB-525 Gene Therapy for Hemophilia A
August 8, 2018
·
9 min read
Deals
REGENXBIO Announces Proposed Public Offering Of $175,000,000 Of Its Common Stock
REGENXBIO Inc. announced that it intends to offer and sell, subject to market conditions, $175,000,000 of its common stock in an underwritten public offering.
August 8, 2018
·
4 min read
Business
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
Achieve Life Sciences, Inc. provided an update on the cytisine clinical development program and announced second quarter 2018 financial results.
August 8, 2018
·
12 min read
Business
PDL BioPharma Reports Second Quarter 2018 Financial Results
PDL BioPharma, Inc. reports financial results for the three and six months ended June 30, 2018
August 8, 2018
·
24 min read
Business
Aerie Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
Conference Call and Webcast Today, August 8th, at 5:00 p.m. ET
August 8, 2018
·
16 min read
BioMidwest
Cardiovascular Systems Presents Liberty 360° Two-Year Outcomes at 2018 Amputation Prevention Symposium
Late-breaking presentation shows high freedom from major amputation
August 8, 2018
·
6 min read
Business
Quanterix Corporation Releases Operating Results for Second Quarter 2018
66% revenue growth
August 8, 2018
·
5 min read
Previous
8 of 20
Next